About

The field was selecting candidates by binding affinity — measurable, scalable, and the wrong variable. Binding does not predict whether a T cell activates, kills, exhausts, or generates cytokine storm.

In 2021, the infrastructure to measure function at scale didn't exist — so we built it. The result: an AI-guided platform and four programmes across myeloma, solid tumours, autoimmune disease, and AML.